While these incretin-based therapies improve glycemic control and promote weight loss, they also influence appetite, gastric emptying, and substrate utilization
As a result, healthcare providers are increasingly considering tirzepatide as part of a comprehensive treatment plan for patients with obesity and type 2 diabetes
When should declining function concern us
Given that the IC 100 concentration of niclosamide required to completely prevent viral replication in SARS-CoV-2 infected Calu-3 lung cells as measured by Ko et al (34) as 2M, a 20uM niclosamide solution nasal spray is 10x this IC 100
How Boost Synergy GLP-1 Supports GLP-1 Secretion GLP-1 is critical in managing appetite, insulin secretion, and weight control
History of Type 2 Diabetes or Obesity You may also be eligible for GLP-1 treatment if you have a medical history of type 2 diabetes, heart disease, or both